Table 3 Clinical and MRI characteristics of patients with SOC from institution B
Characteristics | ODS group | SDS group |
|---|---|---|
Clinical characteristics | ||
Age | 52.95 ± 11.01 | 55.27 ± 5.42 |
Menopausal status | ||
Premenopause | 4 (21.05) | 4 (15.38) |
Postmenopause | 15 (78.95) | 22 (84.62) |
CA125 | 931.9 (391.90, 1384.22) | 1000.50 (404.88, 2526.00) |
HE4 | 260 (129.60, 608.00) | 694.5 (449.00, 1097.00) |
LDH | 299.2 (200.60, 395.40) | 424.45 (269.20, 545.40) |
NLR | 3.52 (2.04, 4.19) | 4.49 (3.28, 6.77) |
ASA | ||
I–II | 19 (100) | 19 (73.08) |
III–IV | 0 | 7 (26.92) |
FIGO stage | ||
I–II | 6 (31.58) | 1 (3.85) |
III–IV | 13 (68.42) | 25 (96.16) |
MRI characteristics | ||
Distribution | ||
Unilateral | 12 (63.16) | 12 (46.15) |
Bilateral | 7 (36.84%) | 14 (53.85) |
Mass feature | ||
Solid | 9 (47.37) | 12 (11.54) |
Complex cystic and solid | 8 (42.11) | 11 (42.31) |
Mainly cystic | 2 (10.53) | 12 (46.15) |
Relationship between the sigmoid colon/rectum and mass | ||
0 (clear, a hook edge existed) | 7 (36.84) | 0 |
The hook edge disappeared | ||
1 (Close) | 4 (21.05) | 5 (19.23) |
2 (Bridge sign) | 7 (36.84%) | 12 (46.15) |
3 (Fusion) | 1 (5.26) | 9 (34.62) |
Bladder invaded | 2 (10.53) | 0 |
Metastases of distant organs | 0 | 3 (11.54%) |
Diaphragmatic metastasis | 4 (21.05) | 16 (61.54) |
Nodules or masses implanted on the omentum/peritoneum | 9 (47.37) | 25 (96.15) |
Hydroureter | 0 | 0 |
Retroperitoneal lymphadenectasis | 5 (26.32) | 1 (3.85) |
Amount of ascites | ||
No ascites or small | 12 (63.16) | 9 (34.62) |
Medium to large | 7 (36.84) | 17 (65.38) |